These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27366084)

  • 1. Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells.
    Liu Y; Sun B; Liu T; Zhao X; Wang X; Li Y; Meng J; Gu Q; Liu F; Dong X; Liu P; Sun R; Zhao N
    Onco Targets Ther; 2016; 9():3473-84. PubMed ID: 27366084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line.
    Maroufi NF; Rashidi M; Vahedian V; Jahanbazi R; Mostafaei S; Akbarzadeh M; Kazemzadeh H; Nejabati HR; Isazadeh A; Rashidi MR; Nouri M
    Breast Cancer; 2022 Mar; 29(2):260-273. PubMed ID: 34725795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer.
    Sun H; Yao N; Cheng S; Li L; Liu S; Yang Z; Shang G; Zhang D; Yao Z
    Cancer Biol Med; 2019 May; 16(2):299-311. PubMed ID: 31516750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry.
    Liu T; Sun B; Zhao X; Li Y; Zhao X; Liu Y; Yao Z; Gu Q; Dong X; Shao B; Lin X; Liu F; An J
    Mol Cancer Ther; 2015 Sep; 14(9):2121-31. PubMed ID: 26232424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel.
    Izawa Y; Kashii-Magaribuchi K; Yoshida K; Nosaka M; Tsuji N; Yamamoto A; Kuroyanagi K; Tono K; Tanihata M; Imanishi M; Onishi M; Sakiyama M; Inoue S; Takahashi R
    Acta Histochem Cytochem; 2018 Dec; 51(6):173-183. PubMed ID: 30647492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress inhibits 3D Matrigel-induced vasculogenic mimicry of breast cancer cells via TGF-β1/Smad2/3 and β-catenin signaling.
    Liu H; Wang H; Chen D; Gu C; Huang J; Mi K
    FEBS Open Bio; 2021 Sep; 11(9):2607-2618. PubMed ID: 34320274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
    Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N
    Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer.
    Wu Q; Wang J; Liu Y; Gong X
    Int J Clin Exp Pathol; 2019; 12(5):1678-1689. PubMed ID: 31933986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells.
    Haiaty S; Rashidi MR; Akbarzadeh M; Bazmani A; Mostafazadeh M; Nikanfar S; Zibaei Z; Rahbarghazi R; Nouri M
    BMC Complement Med Ther; 2021 Mar; 21(1):83. PubMed ID: 33663486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
    Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
    Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells.
    Cui YF; Liu AH; An DZ; Sun RB; Shi Y; Shi YX; Shi M; Zhang Q; Wang LL; Feng Q; Pan GL; Wang Q
    Oncotarget; 2015 May; 6(13):11087-97. PubMed ID: 25871476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of Vasculogenic Mimicry in Breast Cancer.
    Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J
    Front Oncol; 2020; 10():220. PubMed ID: 32175277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer.
    Shen Y; Quan J; Wang M; Li S; Yang J; Lv M; Chen Z; Zhang L; Zhao X; Yang J
    Oncotarget; 2017 Aug; 8(34):56408-56416. PubMed ID: 28915600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
    Tao W; Sun W; Zhu H; Zhang J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells.
    Charfi C; Demeule M; Currie JC; Larocque A; Zgheib A; Danalache BA; Ouanouki A; Béliveau R; Marsolais C; Annabi B
    Front Oncol; 2021; 11():760787. PubMed ID: 34751242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPS1 knockdown inhibits angiogenic vascular mimicry in human triple negative breast cancer cells.
    Wu M; Sun X; Wang T; Zhang M; Li P
    Clin Transl Oncol; 2022 Jan; 24(1):145-153. PubMed ID: 34216368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Exerts Significant Antitumor Effects by Suppressing Vasculogenic Mimicry in Breast Cancer Cells.
    Bajbouj K; Al-Ali A; Shafarin J; Sahnoon L; Sawan A; Shehada A; Elkhalifa W; Saber-Ayad M; Muhammad JS; Elmoselhi AB; Guraya SY; Hamad M
    Front Oncol; 2022; 12():918340. PubMed ID: 35747793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-204 Regulates Angiogenesis and Vasculogenic Mimicry in CD44+/CD24- Breast Cancer Stem-like Cells.
    Resendiz-Hernández M; García-Hernández AP; Silva-Cázares MB; Coronado-Uribe R; Hernández-de la Cruz ON; Arriaga-Pizano LA; Prieto-Chávez JL; Salinas-Vera YM; Ibarra-Sierra E; Ortiz-Martínez C; López-Camarillo C
    Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.